Thienam

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1988-2006
01219882006

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
The presence of the persistence factors (anti-lysozyme and anti-complement activity) in the vegetative forms of C. difficile was… (More)
Is this relevant?
2003
2003
In a number of in vitro experiments the effect of oxytocin on the antilysozyme and anticomplemental activity of Propiobacterium… (More)
Is this relevant?
1998
1998
The authors describe 229 cases of carbapenem use in intensive care wards. Tienam was used in 205 cases since 1993, meronem in 24… (More)
Is this relevant?
1998
1998
The authors present data of using the selective intraarterial infusion of Thienam and Vasaprostan for treatment of purulent… (More)
Is this relevant?
Review
1998
Review
1998
A 3-year experience was reviewed in the treatment of patients with pyoinflammatory processes (PIP) which developed during the… (More)
Is this relevant?
1997
1997
Results of a clinical and microbiological investigation designed to study thienam permit recommending this drug as an urgent… (More)
Is this relevant?
1996
1996
The authors share their experiences with treatment of 12 patients using the antibiotic Tienam. No complications resulting from… (More)
Is this relevant?
1996
1996
As many as 254 patients with acute pyelonephritis were evaluated for the whole range of possible inflammatory process pathogens… (More)
Is this relevant?
1995
1995
The efficacy of thienam, a product of Merck, Sharp and Dohme (USA) composed of imipenem and cylastatin was studied in the… (More)
Is this relevant?
1993
1993
The clinicobacteriological efficacy and tolerance of thienam (imipenem/cylastatin) were studied in the empirical therapy of 38… (More)
Is this relevant?